ANTI-PD-L2
1 paper2 findings
- 1 lab
- Animals1
Outcomes
2Tumour-infiltrating interferon-gamma+ immune cells
upin mice1
1 study
Tumour-infiltrating interferon-gamma+ immune cells
upin mice1
ANTI-PD-L2 increases tumour-infiltrating interferon-gamma+ immune cells in mice.
“αPD-L2 increases tumour-infiltrating interferon-γ+ immune cell prevalence and interferon-γ production in aged but not young melanoma-bearing hosts in an unexpectedly IL-17-dependent manner.”
Animalsin melanoma-bearing hosts
Nature communications19 Nov 2025
Melanoma
downin mice1
1 study
Melanoma
downin mice1
ANTI-PD-L2 decreases melanoma in mice.
“αPD-L2 fails in young B16-bearing mice but is effective in aged.”
Animalsin B16-bearing mice
Nature communications19 Nov 2025
Latest
1 in 12 monthsNature Communications
Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling
Experiments in miceMelanoma